- Home
- RKT vs PTGX Comparison
RKT vs PTGX Comparison
Compare RKT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKT
- PTGX
- Stock Information
- Founded
- RKT 1985
- PTGX 2006
- Country
- RKT United States
- PTGX United States
- Employees
- RKT N/A
- PTGX N/A
- Industry
- RKT Finance: Consumer Services
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- RKT Finance
- PTGX Health Care
- Exchange
- RKT Nasdaq
- PTGX Nasdaq
- Market Cap
- RKT 2.1B
- PTGX 3.3B
- IPO Year
- RKT 2020
- PTGX 2016
- Fundamental
- Price
- RKT $14.26
- PTGX $51.25
- Analyst Decision
- RKT Hold
- PTGX Strong Buy
- Analyst Count
- RKT 12
- PTGX 9
- Target Price
- RKT $14.13
- PTGX $67.11
- AVG Volume (30 Days)
- RKT 14.2M
- PTGX 1.0M
- Earning Date
- RKT 07-31-2025
- PTGX 08-05-2025
- Dividend Yield
- RKT 5.62%
- PTGX N/A
- EPS Growth
- RKT N/A
- PTGX N/A
- EPS
- RKT N/A
- PTGX 0.86
- Revenue
- RKT $5,082,535,000.00
- PTGX $207,801,000.00
- Revenue This Year
- RKT $1.03
- PTGX N/A
- Revenue Next Year
- RKT $33.42
- PTGX $47.15
- P/E Ratio
- RKT $10,276.19
- PTGX $59.19
- Revenue Growth
- RKT 7.23
- PTGX N/A
- 52 Week Low
- RKT $10.06
- PTGX $32.50
- 52 Week High
- RKT $21.38
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- RKT 55.66
- PTGX 45.80
- Support Level
- RKT $13.93
- PTGX $49.86
- Resistance Level
- RKT $15.18
- PTGX $57.24
- Average True Range (ATR)
- RKT 0.59
- PTGX 2.06
- MACD
- RKT -0.00
- PTGX -0.78
- Stochastic Oscillator
- RKT 53.92
- PTGX 16.14
About RKT Rocket Companies Inc.
Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.